TABLE OF CONTENTS:

1 EXECUTIVE SUMMARY
1.1 MARKET ATTRACTIVENESS ANALYSIS 17

1.1.1 GLOBAL OMEGA-3 PUFA MARKET, BY TYPE 18

1.1.2 GLOBAL OMEGA-3 PUFA MARKET, BY SOURCE 19

1.1.3 GLOBAL OMEGA-3 PUFA MARKET, BY APPLICATION 20

1.1.4 GLOBAL OMEGA-3 PUFA MARKET, BY REGION 21

2 MARKET INTRODUCTION
2.1 DEFINITION 22

2.2 SCOPE OF THE STUDY 22

2.3 RESEARCH OBJECTIVE 22

2.4 MARKET STRUCTURE 23

2.5 KEY BUYING CRITERIA 23

3 RESEARCH METHODOLOGY
3.1 RESEARCH PROCESS 24

3.2 PRIMARY RESEARCH 25

3.3 SECONDARY RESEARCH 26

3.4 MARKET SIZE ESTIMATION 26

3.5 FORECAST MODEL 28

3.6 LIST OF ASSUMPTIONS 29

4 MARKET INSIGHTS
5 MARKET DYNAMICS
5.1 INTRODUCTION 32

5.2 DRIVERS 33

5.2.1 FOCUS ON PREVENTIVE HEALTHCARE 33

5.2.2 GROWTH OF APPLICATION INDUSTRIES 33

5.2.3 DRIVERS IMPACT ANALYSIS 34

5.3 RESTRAINT 34

5.3.1 HIGH COSTS OF OMEGA-3 PUFA 34

5.3.2 RESTRAINTS IMPACT ANALYSIS 35

5.4 OPPORTUNITY 35

5.4.1 ALTERNATIVE SOURCES OF OMEGA-3 PUFA 35

5.5 CHALLENGE 35

5.5.1 IRREGULARITIES IN RAW MATERIAL SUPPLY 35

6 MARKET FACTOR ANALYSIS
6.1 VALUE CHAIN ANALYSIS 36

6.1.1 RAW MATERIAL PROCUREMENT 37

6.1.2 PROCESSING 37

6.1.3 PACKAGING 37

6.2 SUPPLY CHAIN ANALYSIS 38

6.3 PORTER'S FIVE FORCES MODEL 39

6.3.1 THREAT OF NEW ENTRANTS 40

6.3.2 BARGAINING POWER OF SUPPLIERS 40

6.3.3 BARGAINING POWER OF BUYERS 40

6.3.4 THREAT OF SUBSTITUTES 40

6.3.5 INTENSITY OF RIVALRY 40

7 GLOBAL OMEGA-3 PUFA MARKET, BY TYPE
7.1 OVERVIEW 41

7.1.1 GLOBAL OMEGA-3 PUFA MARKET ESTIMATES & FORECAST, BY TYPE, 2017-2025 42

7.2 DOCOSAHEXAENOIC ACID (DHA) 42

7.2.1 DOCOSAHEXAENOIC ACID (DHA): MARKET ESTIMATES & FORECAST, BY REGION, 2017-2025 42

7.3 EICOSAPENTAENOIC ACID (EPA) 43

7.3.1 EICOSAPENTAENOIC ACID (EPA): MARKET ESTIMATES & FORECAST, BY REGION, 2017-2025 43

7.4 ALPHA-LINOLENIC ACID (ALA) 44

7.4.1 ALPHA-LINOLENIC ACID (ALA): MARKET ESTIMATES & FORECAST, BY REGION, 2017-2025 44

8 GLOBAL OMEGA-3 PUFA MARKET, BY SOURCE
8.1 OVERVIEW 45

8.1.1 GLOBAL OMEGA-3 PUFA MARKET ESTIMATES & FORECAST, BY SOURCE, 2017-2025 46

8.2 PLANT SOURCES 47

8.2.1 PLANT SOURCES: MARKET ESTIMATES & FORECAST, BY REGION, 2017-2025 47

8.3 MARINE SOURCES 49

8.3.1 MARINE SOURCES: MARKET ESTIMATES & FORECAST, BY REGION, 2017-2025 49

9 GLOBAL OMEGA-3 PUFA MARKET, BY APPLICATION
9.1 OVERVIEW 52

9.1.1 GLOBAL OMEGA-3 PUFA MARKET ESTIMATES & FORECAST, BY APPLICATION, 2017-2025 53

9.2 FUNCTIONAL FOOD & BEVERAGES 53

9.2.1 FUNCTIONAL FOOD & BEVERAGES: MARKET ESTIMATES & FORECAST, BY REGION, 2017-2025 53

9.3 DIETARY SUPPLEMENTS 54

9.3.1 DIETARY SUPPLEMENTS: MARKET ESTIMATES & FORECAST, BY REGION, 2017-2025 54

9.4 INFANT FORMULA 54

9.4.1 INFANT FORMULA: MARKET ESTIMATES & FORECAST, BY REGION, 2017-2025 54

9.5 PHARMACEUTICALS & NUTRACEUTICALS 55

9.5.1 PHARMACEUTICALS & NUTRACEUTICALS: MARKET ESTIMATES & FORECAST, BY REGION, 2017-2025 55

9.6 OTHERS 55

9.6.1 OTHERS: MARKET ESTIMATES & FORECAST, BY REGION, 2017-2025 56

10 GLOBAL OMEGA-3 PUFA MARKET, BY REGION
10.1 OVERVIEW 57

10.2 NORTH AMERICA 59

10.2.1 US 61

10.2.2 CANADA 63

10.2.3 MEXICO 64

10.3 EUROPE 66

10.3.1 GERMANY 68

10.3.2 UK 70

10.3.3 FRANCE 71

10.3.4 SPAIN 73

10.3.5 ITALY 74

10.3.6 REST OF EUROPE 76

10.4 ASIA-PACIFIC 78

10.4.1 CHINA 80

10.4.2 JAPAN 82

10.4.3 INDIA 83

10.4.4 AUSTRALIA & NEW ZEALAND 85

10.4.5 REST OF ASIA-PACIFIC 86

10.5 REST OF THE WORLD (ROW) 88

10.5.1 SOUTH AMERICA 90

10.5.2 MIDDLE EAST 92

10.5.3 AFRICA 93

11 COMPETITIVE LANDSCAPE
11.1 INTRODUCTION 95

11.2 COMPETITIVE BENCHMARKING 96

11.3 KEY DEVELOPMENTS & GROWTH STRATEGIES 97

11.3.1 PRODUCT LAUNCHES 97

11.3.2 JOINT VENTURES 97

12 COMPANY PROFILES
12.1 CARGILL, INCORPORATED 98

12.1.1 COMPANY OVERVIEW 98

12.1.2 FINANCIAL OVERVIEW 99

12.1.3 PRODUCTS OFFERED 99

12.1.4 KEY DEVELOPMENTS 100

12.1.5 SWOT ANALYSIS 100

12.1.6 KEY STRATEGIES 100

12.2 BASF SE 101

12.2.1 COMPANY OVERVIEW 101

12.2.2 FINANCIAL OVERVIEW 101

12.2.3 PRODUCTS OFFERED 102

12.2.4 KEY DEVELOPMENTS 102

12.2.5 SWOT ANALYSIS 103

12.2.6 KEY STRATEGIES 103

12.3 PHARMA MARINE AS 104

12.3.1 COMPANY OVERVIEW 104

12.3.2 FINANCIAL OVERVIEW 104

12.3.3 PRODUCTS OFFERED 104

12.3.4 KEY DEVELOPMENTS 104

12.3.6 SWOT ANALYSIS 105

12.3.7 KEY STRATEGIES 105

12.4 CRODA INTERNATIONAL PLC 106

12.4.1 COMPANY OVERVIEW 106

12.4.2 FINANCIAL OVERVIEW 106

12.4.3 PRODUCTS OFFERED 107

12.4.4 KEY DEVELOPMENTS 107

12.4.5 SWOT ANALYSIS 107

12.4.6 KEY STRATEGIES 107

12.5 POLARIS 108

12.5.1 COMPANY OVERVIEW 108

12.5.2 FINANCIAL OVERVIEW 108

12.5.3 PRODUCTS OFFERED 108

12.5.4 KEY DEVELOPMENTS 108

12.5.5 SWOT ANALYSIS 109

12.5.6 KEY STRATEGIES 109

12.6 PELAGIA AS 110

12.6.1 COMPANY OVERVIEW 110

12.6.2 FINANCIAL OVERVIEW 110

12.6.3 PRODUCTS OFFERED 110

12.6.4 KEY DEVELOPMENTS 110

12.6.5 SWOT ANALYSIS 111

12.6.6 KEY STRATEGIES 111

12.7 OMEGA PROTEIN CORPORATION 112

12.7.1 COMPANY OVERVIEW 112

12.7.2 FINANCIAL OVERVIEW 112

12.7.3 PRODUCTS OFFERED 112

12.7.4 KEY DEVELOPMENTS 112

12.7.5 SWOT ANALYSIS 113

12.7.6 KEY STRATEGIES 113

12.8 ARISTA INDUSTRIES 114

12.8.1 COMPANY OVERVIEW 114

12.8.2 FINANCIAL OVERVIEW 114

12.8.3 PRODUCTS OFFERED 114

12.8.4 KEY DEVELOPMENTS 114

12.8.5 SWOT ANALYSIS 115

12.8.6 KEY STRATEGIES 115

12.9 KONINKLIJKE DSM N.V. 116

12.9.1 COMPANY OVERVIEW 116

12.9.2 FINANCIAL OVERVIEW 116

12.9.3 PRODUCTS OFFERED 117

12.9.4 KEY DEVELOPMENTS 117

12.9.5 SWOT ANALYSIS 117

12.9.6 KEY STRATEGIES 118

12.10 ARJUNA NATURAL PVT LTD 119

12.10.1 COMPANY OVERVIEW 119

12.10.2 FINANCIAL OVERVIEW 119

12.10.3 PRODUCTS OFFERED 119

12.10.4 KEY DEVELOPMENTS 119

12.10.5 SWOT ANALYSIS 120

12.10.6 KEY STRATEGIES 120

13 APPENDIX